Emma Guilbaud

1.9k total citations · 2 hit papers
18 papers, 968 citations indexed

About

Emma Guilbaud is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Emma Guilbaud has authored 18 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Emma Guilbaud's work include interferon and immune responses (4 papers), Autophagy in Disease and Therapy (4 papers) and Mitochondrial Function and Pathology (3 papers). Emma Guilbaud is often cited by papers focused on interferon and immune responses (4 papers), Autophagy in Disease and Therapy (4 papers) and Mitochondrial Function and Pathology (3 papers). Emma Guilbaud collaborates with scholars based in United States, Israel and France. Emma Guilbaud's co-authors include Lorenzo Galluzzi, Takahiro Yamazaki, Saverio Marchi, Stephen W. G. Tait, Guido Kroemer, Darby Schmidt, Francesco M. Marincola, Radek Špíšek, Jitka Fučíková and Iva Truxová and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature reviews. Immunology.

In The Last Decade

Emma Guilbaud

16 papers receiving 963 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial control of inflammation

2022 602 citations Saverio Marchi, Emma Guilbaud et al. Nature reviews. Immunology profile →
Targeting immunogenic cell stress and death for cancer therapy

2024 214 citations Lorenzo Galluzzi, Emma Guilbaud et al. Nature Reviews Drug Discovery profile →

Peers

Emma Guilbaud

MB

IMMUN

ONCOL

EPIDE

BE

Xiaohan Yao China

Anfei Huang China

Charles Drummer United States

Yuan Qiu China

Jing Ma China

Wen Qiu China

Gianni Francesco Guidetti Italy

Huanhuan He China

Xiaoxia Yang China

Rongchen Shi China

Xiaohan Yao China

Emma Guilbaud

499 ×1.1

MB

194 ×0.6

IMMUN

128 ×0.9

ONCOL

72 ×0.5

EPIDE

140 ×1.2

BE

Citations per year, relative to Emma Guilbaud Emma Guilbaud (= 1×) peers Xiaohan Yao

Countries citing papers authored by Emma Guilbaud

Since Specialization

Citations

This map shows the geographic impact of Emma Guilbaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Guilbaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Guilbaud more than expected).

Fields of papers citing papers by Emma Guilbaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Guilbaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Guilbaud. The network helps show where Emma Guilbaud may publish in the future.

Co-authorship network of co-authors of Emma Guilbaud

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Guilbaud. A scholar is included among the top collaborators of Emma Guilbaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Guilbaud. Emma Guilbaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Sato, Ai, Emma Guilbaud, Christina Y. Yim, et al.. (2025). Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112. OncoImmunology. 14(1). 2507245–2507245.

2.

Guilbaud, Emma, et al.. (2025). Context-dependent impact of type I interferon signaling in cancer. Molecular Cancer. 24(1). 275–275. 1 indexed citations

3.

Guilbaud, Emma, et al.. (2025). Impact of radiation therapy on the immunological tumor microenvironment. Cell chemical biology. 32(5). 678–693. 2 indexed citations

4.

Galluzzi, Lorenzo, Emma Guilbaud, & Abhishek D. Garg. (2025). Mitochondrial succinate feeds T cell exhaustion in cancer. Cancer Cell. 43(2). 168–170.

5.

Guilbaud, Emma, Kristopher A. Sarosiek, & Lorenzo Galluzzi. (2024). Inflammation and mitophagy are mitochondrial checkpoints to aging. Nature Communications. 15(1). 3375–3375. 15 indexed citations

6.

Guilbaud, Emma, et al.. (2024). PARP7 and nucleic acid-driven oncosuppression. Cellular and Molecular Immunology. 21(11). 1177–1179. 2 indexed citations

7.

Galluzzi, Lorenzo, Emma Guilbaud, Darby Schmidt, Guido Kroemer, & Francesco M. Marincola. (2024). Targeting immunogenic cell stress and death for cancer therapy. Nature Reviews Drug Discovery. 23(6). 445–460. 214 indexed citations breakdown →

8.

Guilbaud, Emma & Lorenzo Galluzzi. (2024). A mitochondrial checkpoint to NF-κB signaling. Cell Death and Disease. 15(7). 477–477. 2 indexed citations

9.

Guilbaud, Emma, Vanessa Klapp, Iva Truxová, et al.. (2023). Type I interferon and cancer. Immunological Reviews. 321(1). 115–127. 55 indexed citations

10.

Guilbaud, Emma, Guido Kroemer, & Lorenzo Galluzzi. (2023). Calreticulin exposure orchestrates innate immunosurveillance. Cancer Cell. 41(6). 1014–1016. 22 indexed citations

11.

Guilbaud, Emma, et al.. (2023). 1106 Molecular mechanisms of immunogenic cell death driven by PT-112. SHILAP Revista de lepidopterología. A1218–A1218. 2 indexed citations

12.

Marchi, Saverio, Emma Guilbaud, Stephen W. G. Tait, Takahiro Yamazaki, & Lorenzo Galluzzi. (2022). Mitochondrial control of inflammation. Nature reviews. Immunology. 23(3). 159–173. 602 indexed citations breakdown →

13.

Bloy, Norma, Claudia Galassi, Ai Sato, et al.. (2022). Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods in cell biology. 172. 17–36. 1 indexed citations

14.

Guilbaud, Emma, Takahiro Yamazaki, & Lorenzo Galluzzi. (2022). T cell-independent abscopal responses to radiotherapy. Trends in cancer. 9(2). 93–95. 2 indexed citations

15.

Sato, Ai, Norma Bloy, Claudia Galassi, et al.. (2022). Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. Methods in cell biology. 172. 115–134. 1 indexed citations

16.

Guilbaud, Emma, Ana M. Cosialls, Gabriel Pons, et al.. (2021). The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells. Oncogenesis. 10(9). 64–64. 17 indexed citations

17.

Abdel‐Wahab, Omar, Stoyan Ivanov, Rodolphe Guinamard, et al.. (2020). ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms. Cell Reports. 30(10). 3397–3410.e5. 17 indexed citations

18.

Guilbaud, Emma, Emmanuel L. Gautier, & Laurent Yvan‐Charvet. (2019). Macrophage Origin, Metabolic Reprogramming and IL-1β Signaling: Promises and Pitfalls in Lung Cancer. Cancers. 11(3). 298–298. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact